587
Views
2
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality

, , , , &
Pages 702-704 | Received 19 Jul 2006, Published online: 08 Jul 2009

References

  • Ortega C, Faggiuolo R, Vormola R, Montemurro F, Nanni D, Goia F, et al. Jaw complications in breast and prostate cancer patients treated with zoledronic acid. Acta Oncol 2006; 45: 216–7
  • Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy. Cancer 2005; 104: 83–93
  • Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115–7
  • Conte P, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 2004; 9(Suppl 4)28–37
  • Stamenkovic I. Extracellular matrix remodelling: The role of matrix metalloproteinases. J Pathol 2003; 200: 448–64
  • Van den Wyngaert T, Huizing MT, Vermorken JB. Bisphosphonates and osteonecrosis of the jaw: Cause and effect or a post hoc fallacy?. Ann Oncol 2006; 17: 1197–204
  • Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Grundker C, et al. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002; 291: 680–6
  • Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005; 63: 1567–75
  • Behrman, Kliegman, Arvin. Textbook of paediatrics. 15th ed. P 1980–1.
  • Junquera L, Rodriguez-Recio C, Villarreal P, Garcia-Consuegra L. Autosomaldominant osteopetrosis and maxillomandibular osteomyelitis. Am J Otolaryngol 2005; 26: 275–8
  • Batra P, Shah N. Recalcitrant osteomyelitis following tooth extraction in a case of malignant osteopetrosis. Int Dent J 2004; 54: 418–23
  • Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate induced osteopetrosis. N Engl J Med 2003; 349: 457–63
  • Bruder E, Stallmach T, Peier K, Superti-Furga A, Vezzoni P. Osteoclast morphology in autosomal recessive malignant osteopetrosis due to a TCIRG1 gene mutation. Pediatr Pathol Mol Med 2003; 22: 3–9
  • Shapiro F, Key LL, Anast C. Variable osteoclast appearance in human infantile osteopetrosis. Calcif Tissue Int 1988; 43: 67–76
  • Ito M, Amizuka N, Nakajima T, Ozawa H. Bisphosphonate acts on osteoclasts independent of ruffled borders in osteosclerotic (oc/oc) mice. Bone 2001; 28: 609–16
  • Ito M, Amizuka N, Nakajima T, Ozawa H. Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 1999; 25: 447–52
  • Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991; 88: 2095–105
  • Kelleher FC, McKenna M, Collins C, Brady G, Crown J. ASCO Annual Meeting Proceedings Part 1. No. 18S (June 20 Supplement). J Clin Oncol 2006; 24: 18621
  • Juniper RP. Caffey's disease. Br J Oral Surg 1982; 20: 281–7
  • Kawamoto S, Ejiri S, Hoshi K, Nagaoka E, Ozawa H. Immunolocalization of osteoclast differentiation factor in rat periodontium. Arch Oral Biol 2002; 47: 55–8
  • Yoshimine Y, Tsukuba T, Isobe R, Sumi M, Akamine A, Maeda K, et al. Specific immunocytochemical localization of cathepsin E at the ruffled border membrane of active osteoclasts. Cell Tissue Res 1995; 281: 85–91
  • Gahleitner A, Hofschneider U, Tepper G, Pretterklieber M, Schick S, Zauza K, et al. Lingual vascular canals of the mandible: Evaluation with dental CT. Radiology 2001; 220: 186–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.